314 related articles for article (PubMed ID: 33692340)
21. MicroRNA-205-5p Promotes Unstable Atherosclerotic Plaque Formation In Vivo.
Meng X; Yin J; Yu X; Guo Y
Cardiovasc Drugs Ther; 2020 Feb; 34(1):25-39. PubMed ID: 32034643
[TBL] [Abstract][Full Text] [Related]
22. Biochanin A Mitigates Atherosclerosis by Inhibiting Lipid Accumulation and Inflammatory Response.
Yu XH; Chen JJ; Deng WY; Xu XD; Liu QX; Shi MW; Ren K
Oxid Med Cell Longev; 2020; 2020():8965047. PubMed ID: 33959213
[TBL] [Abstract][Full Text] [Related]
23. G004, a synthetic sulfonylurea compound, exerts anti-atherosclerosis effects by targeting SIRT1 in ApoE
Qian L; Ma L; Wu G; Yu Q; Lin H; Ying Q; Wen D; Gao C
Vascul Pharmacol; 2017 Feb; 89():49-57. PubMed ID: 28069546
[TBL] [Abstract][Full Text] [Related]
24. LongShengZhi Capsule Reduces Established Atherosclerotic Lesions in apoE-Deficient Mice by Ameliorating Hepatic Lipid Metabolism and Inhibiting Inflammation.
Ma J; Zhao D; Wang X; Ma C; Feng K; Zhang S; Chen Y; Zhu Y; Gao X; Zhao B; Wang Y; Qian K; Li X; Duan Y; Han J; Yang X
J Cardiovasc Pharmacol; 2019 Feb; 73(2):105-117. PubMed ID: 30540683
[TBL] [Abstract][Full Text] [Related]
25. Sonodynamic therapy-induced foam cells apoptosis activates the phagocytic PPARγ-LXRα-ABCA1/ABCG1 pathway and promotes cholesterol efflux in advanced plaque.
Wang H; Yang Y; Sun X; Tian F; Guo S; Wang W; Tian Z; Jin H; Zhang Z; Tian Y
Theranostics; 2018; 8(18):4969-4984. PubMed ID: 30429880
[TBL] [Abstract][Full Text] [Related]
26. Retinoic acid induces macrophage cholesterol efflux and inhibits atherosclerotic plaque formation in apoE-deficient mice.
Zhou W; Lin J; Chen H; Wang J; Liu Y; Xia M
Br J Nutr; 2015 Aug; 114(4):509-18. PubMed ID: 26201974
[TBL] [Abstract][Full Text] [Related]
27. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
[TBL] [Abstract][Full Text] [Related]
28. Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice.
van der Sluis RJ; Nahon JE; Reuwer AQ; Van Eck M; Hoekstra M
Br J Pharmacol; 2015 May; 172(9):2397-405. PubMed ID: 25572138
[TBL] [Abstract][Full Text] [Related]
29. Polydatin attenuates atherosclerosis in apolipoprotein E-deficient mice: Role of reverse cholesterol transport.
Peng Y; Xu J; Zeng Y; Chen L; Xu XL
Phytomedicine; 2019 Sep; 62():152935. PubMed ID: 31085374
[TBL] [Abstract][Full Text] [Related]
30. LncRNA kcnq1ot1 promotes lipid accumulation and accelerates atherosclerosis via functioning as a ceRNA through the miR-452-3p/HDAC3/ABCA1 axis.
Yu XH; Deng WY; Chen JJ; Xu XD; Liu XX; Chen L; Shi MW; Liu QX; Tao M; Ren K
Cell Death Dis; 2020 Dec; 11(12):1043. PubMed ID: 33293505
[TBL] [Abstract][Full Text] [Related]
31. Dihydromyricetin ameliorates foam cell formation via LXRα-ABCA1/ABCG1-dependent cholesterol efflux in macrophages.
Zeng Y; Peng Y; Tang K; Wang YQ; Zhao ZY; Wei XY; Xu XL
Biomed Pharmacother; 2018 May; 101():543-552. PubMed ID: 29505925
[TBL] [Abstract][Full Text] [Related]
32. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
[TBL] [Abstract][Full Text] [Related]
33. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
34. Ablation of Myeloid ADK (Adenosine Kinase) Epigenetically Suppresses Atherosclerosis in ApoE
Zhang M; Zeng X; Yang Q; Xu J; Liu Z; Zhou Y; Cao Y; Zhang X; An X; Xu Y; Huang L; Han Z; Wang T; Wu C; Fulton DJ; Weintraub NL; Hong M; Huo Y
Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2780-2792. PubMed ID: 30571174
[TBL] [Abstract][Full Text] [Related]
35. Asprosin inhibits macrophage lipid accumulation and reduces atherosclerotic burden by up-regulating ABCA1 and ABCG1 expression via the p38/Elk-1 pathway.
Zou J; Xu C; Zhao ZW; Yin SH; Wang G
J Transl Med; 2022 Jul; 20(1):337. PubMed ID: 35902881
[TBL] [Abstract][Full Text] [Related]
36. LncRNA KCNQ1OT1 depletion inhibits the malignant development of atherosclerosis by miR-145-5p.
Wang Y; Liu L; Li J
Microvasc Res; 2022 Jan; 139():104236. PubMed ID: 34464666
[TBL] [Abstract][Full Text] [Related]
37. TRIM13 reduces cholesterol efflux and increases oxidized LDL uptake leading to foam cell formation and atherosclerosis.
Govatati S; Kumar R; Boro M; Traylor JG; Orr AW; Lusis AJ; Rao GN
J Biol Chem; 2024 May; 300(5):107224. PubMed ID: 38537695
[TBL] [Abstract][Full Text] [Related]
38. TIGAR mitigates atherosclerosis by promoting cholesterol efflux from macrophages.
Zhao ZW; Zhang M; Zou J; Wan XJ; Zhou L; Wu Y; Liu SM; Liao LX; Li H; Qin YS; Yu XH; Tang CK
Atherosclerosis; 2021 Jun; 327():76-86. PubMed ID: 33994201
[TBL] [Abstract][Full Text] [Related]
39. DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice.
Wang J; Xu P; Xie X; Li J; Zhang J; Wang J; Hong F; Li J; Zhang Y; Song Y; Zheng X; Zhai Y
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28971954
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-23a-5p promotes atherosclerotic plaque progression and vulnerability by repressing ATP-binding cassette transporter A1/G1 in macrophages.
Yang S; Ye ZM; Chen S; Luo XY; Chen SL; Mao L; Li Y; Jin H; Yu C; Xiang FX; Xie MX; Chang J; Xia YP; Hu B
J Mol Cell Cardiol; 2018 Oct; 123():139-149. PubMed ID: 30227118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
